Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.
about
Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients.Human leukocyte antigen (HLA)-G gene polymorphism in patients with non-small cell lung cancerHuman Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage.Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?HLA-G expression in cancers: roles in immune evasion, metastasis and target for therapyHLA-G regulators in cancer medicine: an outline of key requirements.The immunosuppressive molecule HLA-G and its clinical implications.The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases.Importance of the plasma soluble HLA-G levels for prognostic stratification with traditional prognosticators in colorectal cancer.Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.Cancer treatment and the KIR-HLA system: an overview.Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor.Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells.Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling.Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.Evaluation of ascitic soluble human leukocyte antigen-G for distinguishing malignant ascites from benign ascites.Human leukocyte antigen-G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment.Update on immune checkpoint inhibitors in lung cancerHeterogeneity of HLA-G Expression in Cancers: Facing the ChallengesClinical Significance of Potential Unidentified HLA-G Isoforms Without α1 Domain but Containing Intron 4 in Colorectal Cancer Patients
P2860
Q35390989-E0501107-0DB7-46C0-84B3-86B6D8EDBB5BQ36051715-AF9DB39F-4E12-402C-BBCA-423E0A2406CDQ36102549-24337F2D-05F6-4775-B403-106402A7F547Q36184793-A6654CB4-F949-4F62-B8A2-D10728AA57EBQ36568297-44E8F816-99C7-435D-B457-8F9283587DD5Q37906387-DDE483D7-BBC8-4D2A-B6EB-FA0B7BB08FF8Q38005743-BAB25A80-03CD-4B28-8981-A17A9843AF3FQ38362617-E9830B97-A8E6-4942-866D-E0725D98520CQ38834083-23DDD3B1-39E1-4DB0-BA0E-FED2B6FBF592Q38839707-C3B51F30-BE56-42BD-8C2A-1F3D81DDE24FQ39131056-C22DF31A-B697-4EE4-AEAD-75F0878E47E6Q39348282-00CEE2E8-E989-4188-B8A9-19C031174C05Q39564214-25C3CCBD-E990-4290-98B0-0E750702871FQ40873556-CA260E22-D99C-498D-B029-3F0A2CE99B25Q45061505-D2B3E378-6D1E-4798-834B-EC0E3B33C2BFQ47410788-9A373F15-C080-4332-AFD7-B2CE2F90260EQ49335253-59C941D7-29FC-4201-A5F9-C97F908199F0Q56897146-F7895ADD-EF7B-4ED3-8FBE-0EE49D4D38B0Q57490851-ED5B8A64-247A-4DE0-A26B-E0A3B1F77FE2Q58764745-C4CB370B-994C-4347-BEC0-FAF206FEFF93
P2860
Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical relevance and functio ...... in non-small-cell lung cancer.
@en
Clinical relevance and functio ...... in non-small-cell lung cancer.
@nl
type
label
Clinical relevance and functio ...... in non-small-cell lung cancer.
@en
Clinical relevance and functio ...... in non-small-cell lung cancer.
@nl
prefLabel
Clinical relevance and functio ...... in non-small-cell lung cancer.
@en
Clinical relevance and functio ...... in non-small-cell lung cancer.
@nl
P2093
P2860
P1476
Clinical relevance and functio ...... in non-small-cell lung cancer.
@en
P2093
P2860
P304
P356
10.1111/J.1582-4934.2009.00858.X
P577
2010-09-01T00:00:00Z